Skip to main content
Premium Trial:

Request an Annual Quote

Funds for a Mammoth

Investor Peter Thiel has reportedly infused the project to bring back the woolly mammoth with $100,000, Technology Review reports.

According to Tech Review's Antonio Regalado, Ben Mezrich's new book on the effort by Harvard Medical School's George Church and others to resurrect the woolly mammoth using CRISPR and other genome-editing tools reports that Thiel invested in the project in 2015.

Church tells Regalado that he had breakfast with Thiel and that Thiel wanted to fund the most outlandish project Church was working on. Church says he gave him three options, including a gene therapy-based anti-aging project, using human neurons to develop artificial intelligence, and the mammoth, and Thiel went for the mammoth project.

Stewart Brand, who co-founded Revive & Restore along with Ryan Phelan, adds, though, that the project isn't well funded. "The reality is that no big money is going into it. It's our own money, except for Thiel," he says

Business Insider adds that the project wouldn't truly bring back the woolly mammoth, but rather create an elephant-woolly mammoth hybrid. In addition, Regalado notes that the mammoth project appears to be "a back-burner operation that's advancing fitfully at best."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.